← Back to patent-cliff list
VH-4524184
Tier C — Watch / tradeVH-4524184
Shionogi & Co., Ltd.
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HIV integrase
Indications (approved)：HIV infection
Regional status
US
Phase II
2024-02-07
EU
Phase II
2024-02-07
China
-
Japan
Phase II
2026-02-11
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of VH-4524184?
Approved indications include: HIV infection.
When does the VH-4524184 patent expire?
No public expiry year is available for VH-4524184 yet; this page updates once verified.
How do I get a quote for VH-4524184 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01